Bio‐Inspired In Situ Injectable Hemostatic Agent with Covalent‐Ionic Hybrid Network for Non‐Compressible Hemorrhage
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202503697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Xiao-Suan Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Fourth Military Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Hemostatics, Hemorrhage. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Projects of Shaanxi Province.
Abstract (Originalsprache)
Non‐compressible hemorrhage is an arduous clinical challenge that primarily occurs at thoracic/abdominal solid organ injuries, deep arterial ruptures, and major vascular trauma, and cannot be stopped by compressing the hemorrhage site. Currently available commercial hemostatic materials for non‐compressible hemorrhage are plagued by issues such as poor sealing ability and insufficient hemostatic performance. In the current work, tetra‐PEG‐succinimidyl glutarate (TPEG‐SG), carboxymethyl chitosan (CMCS), and the coagulation factor Ca 2 + were used as the primary ingredients to create a covalent‐ionic hybrid crosslinked hemostatic agent TPEG‐SG/CMCS/Ca 2 + . The optimal formula of hemostatic agent was screened by using response surface methodology. The obtained hemostatic agent TPEG‐SG/CMCS/Ca 2 + could achieve rapid and ultra‐high sealing ability, with a burst pressure of 354 mmHg. It also demonstrated excellent hemostatic ability in vivo, outperforming the commercial fibrin glue in hemostasis including mouse liver and inferior vena cava hemorrhage models, rabbit renal incision, partial hepatectomy, femoral artery puncture, and lethal rabbit carotid artery puncture hemorrhage models, showing great potential in non‐compressible hemorrhage hemostasis. In addition, in the mouse full‐thickness skin incision model, the hemostatic agent was superior to fibrin glue in wound closure and repair. Overall, the TPEG‐SG/CMCS/Ca 2 + hemostatic agent showed promising clinical application potential in the management of non‐compressible hemorrhage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmacy, Fourth Military Medical University, Xi'an, China.
- Department of Pharmacy, Xijing 986 Hospital, Fourth Military Medical University, Xi'an, China.
- Key Laboratory of Pharmacology of the State Administration of Traditional Chinese Medicine, Fourth Military Medical University, Xi'an, China.
- Department of Chemistry, School of Pharmacy, Fourth Military Medical University, Xi'an, China.
Förderung
- National Natural Science Foundation of China
- Key Research and Development Projects of Shaanxi Province
Zitieren
APA
Zhou, X. S., Cai, Z., Li, Y. Y., He, W., Zhang, T. R., Zhou, S. Y., & Zhang, B. L. (2026). Bio‐Inspired In Situ Injectable Hemostatic Agent with Covalent‐Ionic Hybrid Network for Non‐Compressible Hemorrhage. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503697
Vancouver
Zhou XS, Cai Z, Li YY, He W, Zhang TR, Zhou SY, et al. Bio‐Inspired In Situ Injectable Hemostatic Agent with Covalent‐Ionic Hybrid Network for Non‐Compressible Hemorrhage. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202503697
BibTeX
@article{Zhou2026,
author = {Zhou, Xiao-Suan and Cai, Zedong and Li, Yu-Yao and He, Wei and Zhang, Tang-Rui and Zhou, Si-Yuan and Zhang, Bang-Le},
title = {Bio‐Inspired In Situ Injectable Hemostatic Agent with Covalent‐Ionic Hybrid Network for Non‐Compressible Hemorrhage},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202503697}
}
EUVIMED